Clinical Insights: July 14, 2020
Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval UpneeqTM (oxymetazoline hydrochloride) Ophthalmic Solution – New Drug Approval – July 8, 2020 – Osmotica Pharmaceuticals plc, a fully integrated biopharmaceutical company, announced that the U.S. Food and…
Clinical Insights: July 7, 2020
Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval ByfavoTM (remimazolam) Injection – New Drug Approval – July 2, 2020 – Cosmo Pharmaceuticals announced that the US Food and Drug Administration (FDA) has approved Byfavo™ (remimazolam injection)…
Clinical Insights: June 30, 2020
Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval Fintepla® (fenfluramine) Oral Solution – New Drug Approval – June 26, 2020 – The U.S. Food and Drug Administration approved Fintepla® (fenfluramine), a Schedule IV controlled substance, for…
Clinical Insights: June 23, 2020
Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval GimotiTM (metoclopramide) Nasal Spray – New Drug Approval – June 19, 2020 – Evoke Pharma, Inc., a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, announced…
Clinical Insights: June 16, 2020
Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval ZepzelcaTM (lurbinectedin) Injection – New Drug Approval – June 15, 2020 – PharmaMar announced, along with Jazz Pharmaceuticals plc, that the U.S. Food and Drug Administration (FDA) has…
Clinical Insights: June 9, 2020
Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval No new update. New Formulation Approval No new update. New Indication Approval RecarbrioTM (imipenem-cilastatin and relebactam) Injection – New Drug Indication Approval – June 4, 2020 –…
Clinical Insights: June 2, 2020
Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval OriahnnTM (elagolix/estradiol/norethindrone acetate and elagolix) Capsules – New Drug Approval – May 29, 2020 – The U.S. Food and Drug Administration granted approval to OriahnnTM (an estrogen and…
Clinical Insights: May 27, 2020
Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval PhexxiTM (lactic acid, citric acid and potassium bitartrate) Vaginal Gel – New Drug Approval – May 22, 2020 – Evofem Biosciences, Inc. announced that the U.S. Food…
Connect with RxStrategies at the 2020 Virtual Spring Hospital Pharmacy Conference
RxStrategies’ Rhodie Smith will attend the 2020 Virtual Spring Hospital Pharmacy Conference. Providing educational sessions and meeting opportunities, the conference brings industry providers and suppliers together in a new virtual event format to learn, connect, and support each other. Utilizing its virtual format, the conference will also include a Virtual Reverse Expo, which facilitates…
Clinical Insights: May 19, 2020
Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval QinlockTM (ripretinib) Tablets – New Drug Approval – May 15, 2020 – The U.S. Food and Drug Administration approved QinlockTM (ripretinib) tablets as the first new drug specifically…
Clinical Insights: May 12, 2020
Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval RetevmoTM (selpercatinib) Capsules – New Drug Approval – May 8, 2020 – The U.S. Food and Drug Administration approved RetevmoTM (selpercatinib) capsules to treat three types of tumors…
Clinical Insights: May 5, 2020
Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval Darzalex FasproTM (daratumumab and hyaluronidase-fihj) Injection – New Drug Approval – May 1, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the U.S. Food…